Last year’s DPHARM made one thing clear: clinical research must be patient-centric and AI-empowered. At TrialX, we’re turning that vision into reality by building a better way to manage clinical trials. Through our unified platform, we are on a mission to make trial management smarter and more efficient for everyone—from streamlining complex patient recruitment workflows and expanding trial access for diverse participants, to supporting decentralized research on Earth and in space. We can’t wait to share what we’ve been working on alongside a top sponsor and continue the conversation at Booth #535. See you in Boston this September! 🚀
🕵 What We’re Hearing From The Field
Over my 20+ years in the life sciences industry—and particularly in patient recruitment—I’ve consistently heard the same challenge from sponsors: sites are overwhelmed with referrals that don’t meet key eligibility criteria. Every unqualified referral requires valuable staff time to review, follow up with, and ultimately decline, creating unnecessary burden and slowing enrollment. It’s a virtuous cycle: when sponsors provide sites with higher-quality, pre-qualified referrals, site burden decreases, site engagement improves, and participation in future studies becomes stronger.
Today’s technology is making that possible in ways that weren’t feasible just a few years ago. AI-powered trial matching, intelligent prescreening, configurable eligibility workflows, and real-time referral management enable sponsors to identify better-qualified participants earlier in the process and route them to the right sites with greater accuracy.
At TrialX, we’ve built these capabilities into one command center that combines patient-friendly trial search, AI-assisted prescreening, referral tracking, site workflows, and analytics. The result is a more efficient recruitment process that benefits everyone involved—participants find the right studies faster, sites spend less time screening ineligible candidates, and sponsors gain greater visibility into recruitment performance while accelerating enrollment. Looking forward to meet you at DPharm 2026!
Beth Dickson, VP, Business Development
What’s New at TrialX! 🚀
We are excited to announce the launch of our refreshed digital home highlighting our unified, enterprise-grade global platform designed to accelerate clinical trial recruitment and engagement. Driven by a mission of innovation since 2008, TrialX provides a single “command center” that replaces fragmented tools, allowing sponsors to bring all vendors and sites into one ecosystem while maintaining total ownership of their recruitment data. Our updated site showcases how we are moving the industry forward with AI-assisted trial matching, global clinical trial enrollment, and specialized remote research solutions that scale from Earth to space. Visit trialx.com to see how we are building a better way to manage clinical trials.
❇️ PRODUCT HIGHLIGHTS
CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a rare genetic condition affecting small blood vessels in the brain, often leading to vascular cognitive impairment and dementia. We are proud to empower researchers at the University of Wisconsin with a custom mobile research app designed to capture critical insights into how CADASIL progresses, paving the way for better care and future interventions. Learn More.
We recently launched powerful automation and outreach features in our patient recruitment management platform. With Smart Automations, study teams can now trigger email notifications before, after, or immediately following predefined events, with the ability to localize content by selecting specific country and language variants so patients receive messages in their preferred tongue. In addition, the updated outreach workflow provides study teams with configurable and flexible email templates. Researchers can easily build templates from scratch or modify existing default templates as a base to create user-specific versions tailored to their individual workflows.
At this year’s Aerospace Medical Association (AsMA) conference, our team had an incredible time showcasing how our Space Health Platform powers TRISH HERMES and redefines care beyond Earth. From offline-capable workflows to AI agents guiding zero-gravity workouts, we demonstrated how our platform unifies wearable metrics, genomics, and clinical data to support autonomous crew health in extreme environments. Our Co-founder & CTO Chintan Patel, quotes “A major theme throughout the conference was the growing role of AI agents in supporting healthcare beyond low Earth orbit, particularly as missions become longer, more autonomous, and increasingly distant from Earth-based medical teams. These discussions reinforced the importance of building integrated platforms that combine clinical workflows, research protocols, sensor data, medical inventory management, offline capability, and intelligent decision support.” Learn More About TrialX Space Health Platform.
🎥 RECENT WEBINAR
Patients searching for clinical trials are often met with dense, technical language designed for scientific audiences, not for people trying to decide whether a study is right for them. If you’re part of a pharma, academic medical center, or patient advocacy organization looking to make trial information more accessible, we invite you to watch this webinar where we share how AI, guided by thoughtful prompt design, can turn technical listings into clear, patient-friendly summaries—without losing accuracy. You will also hear perspectives on using AI simplified listings from Krista Goedel of Sanofi.
đź“ş MEDIA & PRESS
Our Co-founder & CEO, Sharib Khan, was featured in Clinical Research News in the article “Space Health Research Could Rack Up Many Earthly Dividends.” The piece highlights how our space health research innovations – developed in collaboration with the Translational Research Institute for Space Health (TRISH), are enabling the collection of vital human health data from commercial spaceflights, with implications that extend beyond astronauts to advance clinical research on Earth. Read the full story.
🎓 SPOTLIGHT
UNSUNG BUT IMPACTFUL VOICES OF CLINICAL RESEARCH HEROES
Behind every clinical breakthroughs are professionals making research more accessible and patient-focused. In our latest spotlight, we sit down with Kyla Godorecci, University of Pennsylvania & CHOP to discuss how she balances complex operations with participant-centered care—and why “meeting people where they are” is the key to better trial management. đź”— Read the interview.
RECENT CURETALKS 
In this CureTalks session, world-renowned geneticist and cardiologist Dr. Kiran Musunuru and CEO of Global Genes, Charlene Son Rigby discuss how breakthroughs in gene editing are transforming care—from lowering cholesterol to developing personalized therapies for rare genetic disorders—and what this means for the future of precision medicine. Watch here.
🧬 FEATURED CLINICAL STUDIES
Powered by TrialX
Myotonic Dystrophy Type 1 Gene Therapy Trial: Researchers are investigating a gene therapy for adults with Myotonic Dystrophy Type 1 (DM1). Participants receive a one-time infusion and are monitored over time to evaluate the treatment’s safety and its potential to improve muscle function.
BEETHOVEN C. difficile Vaccine Trial: Researchers are testing an investigational vaccine designed to help prevent C. difficile infection in adults aged 65 and older who are at increased risk. Participants receive two doses of the vaccine or placebo to evaluate its safety and effectiveness in preventing infection.
Oral Sugar Sensing Study: Researchers at Penn Medicine and the Monell Chemical Senses Center are studying how hunger affects the way people taste sugar. Participants complete taste tests before and after eating a meal, helping researchers better understand taste sensitivity and carbohydrate perception.
Tooth Wear & Sensitivity Study: Indiana University researchers are studying how common tooth wear and tooth sensitivity are in adults. Participants complete a short questionnaire, undergo a digital dental scan, and take a simple sensitivity test to help improve understanding of long-term oral health.
🌎 AROUND THE WEB
🧬 Cell rewind: Scientists test a cell-rejuvenation therapy in a person for the very first time.
🎗️ Trial access: The FDA finalizes new guidance to broaden eligibility for cancer trials.
🌕 Moon mission: NASA to send two lunar probes to test complex orbits.
đź’Š HIV progress: A new oral HIV pill passes its first clinical trial in humans.
🧠Alzheimer’s breakthrough: A new drug repairs DNA damage, reduces brain inflammation
‼️ NOTEWORTHY
At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on AI powered solutions to simplify global patient recruitment management and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!
Get in touch to learn more.
Team TrialX
